1. Home
  2. NRXP vs MHUA Comparison

NRXP vs MHUA Comparison

Compare NRXP & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • MHUA
  • Stock Information
  • Founded
  • NRXP 2015
  • MHUA 1990
  • Country
  • NRXP United States
  • MHUA China
  • Employees
  • NRXP N/A
  • MHUA N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • NRXP Health Care
  • MHUA Health Care
  • Exchange
  • NRXP Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • NRXP 14.8M
  • MHUA 12.8M
  • IPO Year
  • NRXP N/A
  • MHUA 2022
  • Fundamental
  • Price
  • NRXP $1.16
  • MHUA $0.51
  • Analyst Decision
  • NRXP Strong Buy
  • MHUA
  • Analyst Count
  • NRXP 3
  • MHUA 0
  • Target Price
  • NRXP $31.33
  • MHUA N/A
  • AVG Volume (30 Days)
  • NRXP 153.3K
  • MHUA 1.0M
  • Earning Date
  • NRXP 11-18-2024
  • MHUA 11-22-2024
  • Dividend Yield
  • NRXP N/A
  • MHUA N/A
  • EPS Growth
  • NRXP N/A
  • MHUA 29.93
  • EPS
  • NRXP N/A
  • MHUA 0.37
  • Revenue
  • NRXP N/A
  • MHUA $94,252,537.00
  • Revenue This Year
  • NRXP N/A
  • MHUA N/A
  • Revenue Next Year
  • NRXP N/A
  • MHUA N/A
  • P/E Ratio
  • NRXP N/A
  • MHUA $1.41
  • Revenue Growth
  • NRXP N/A
  • MHUA N/A
  • 52 Week Low
  • NRXP $1.10
  • MHUA $0.45
  • 52 Week High
  • NRXP $7.33
  • MHUA $2.81
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 33.72
  • MHUA 33.75
  • Support Level
  • NRXP $1.23
  • MHUA $0.45
  • Resistance Level
  • NRXP $1.30
  • MHUA $0.84
  • Average True Range (ATR)
  • NRXP 0.10
  • MHUA 0.06
  • MACD
  • NRXP 0.00
  • MHUA -0.01
  • Stochastic Oscillator
  • NRXP 12.12
  • MHUA 16.88

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: